20 Participants Needed

Nerve Block for Reducing Pain After Wisdom Tooth Extraction

GS
SY
Overseen BySamuel YP Quek, DMD, MPH
Age: 18 - 65
Sex: Any
Trial Phase: Phase 2
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications for this trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you have an allergy to dental local anesthetics or cannot tolerate common pain medications like opioids, acetaminophen, or ibuprofen, you may not be eligible to participate.

What data supports the effectiveness of the treatment Temporo-masseteric Nerve Block, Twin Block, TMNB for reducing pain after wisdom tooth extraction?

The twin block, which is part of the Temporo-masseteric Nerve Block, has been shown to be effective in managing masticatory myofascial pain, suggesting it may help reduce pain after wisdom tooth extraction.12345

Is the twin block nerve block safe for humans?

The twin block nerve block has been used in studies for managing pain, such as masticatory myofascial pain, and no specific safety concerns have been highlighted in the available research.14678

How does the nerve block treatment for wisdom tooth extraction differ from other treatments?

The nerve block treatment for wisdom tooth extraction is unique because it provides targeted pain relief by blocking specific nerves, reducing the need for opioids or NSAIDs, which can have side effects. This approach is similar to other nerve block techniques used in different dental and facial surgeries, offering effective pain management without the systemic effects of traditional pain medications.12359

What is the purpose of this trial?

This is a pilot study evaluating the ability of the Temporo-masseteric Nerve Block local anesthetic injection (this was called the Twin Block earlier) to reduce pain experienced by individuals undergoing removal of lower third molar(s) under intravenous sedation. Study participants will be queried for pain experience and pain medications taken during the first post-operative week and will present for a follow-up visit on Day 8.

Research Team

GD

Gayathri D Subramanian, PhD, DMD

Principal Investigator

Rutgers School of Dental Medicine

Eligibility Criteria

This trial is for adults aged 18-64 who need their lower wisdom teeth removed and can consent to the study. They must be healthy enough for sedation, not pregnant, have internet access with a smartphone, and able to take common pain meds like Tylenol or Advil.

Inclusion Criteria

My background or age does not limit my participation.
Not pregnant (as will not qualify to undergo procedure under intravenous sedation as part of routine standard-of-care)
I understand the details of the clinical trial and can give informed consent.
See 2 more

Exclusion Criteria

I have difficulty opening my mouth, with or without pain.
Pregnant
I am unable to understand and give consent for treatment.
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Procedure and Immediate Post-Procedure

Participants undergo lower wisdom molar extraction under intravenous sedation and receive the TMNB injection. Pain scores are recorded up to 4 hours post-procedure.

1 day
1 visit (in-person)

Post-operative Monitoring

Participants' pain experience and medication use are monitored daily for one week post-procedure. Adverse effects are also recorded.

1 week
Remote monitoring

Follow-up

Participants return for a post-operative evaluation to assess healing and any adverse effects.

1 day
1 visit (in-person)

Treatment Details

Interventions

  • Temporo-masseteric Nerve Block
Trial Overview The study tests if a local anesthetic injection called Temporo-masseteric Nerve Block reduces pain after wisdom tooth removal under sedation. Participants will report their pain levels and medication use over the first week post-surgery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Temporo-masseteric Nerve Block (TMNB) Injection with Local AnestheticExperimental Treatment1 Intervention
Following lower third molar extraction under intravenous sedation, the patient will receive the TMNB local anesthetic nerve block using the standard dental local anesthetic, i.e,. 2% lidocaine with 1:100,000 epinephrine, on the side/s of lower wisdom molar extraction/s

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Findings from Research

The twin block nerve block technique is effective for the long-term management of masticatory myofascial pain, showing similar pain reduction to trigger point injections over a 6-month period in a study of 40 patients.
Both treatment methods resulted in significant pain reduction from baseline (around 6.5) to follow-up (around 1.85), but there were no statistically significant differences in pain intensity between the two groups, indicating that the twin block is a viable alternative to trigger point injections.
The effect of the twin block compared with trigger point injections in patients with masticatory myofascial pain: a pilot study.Ananthan, S., Kanti, V., Zagury, JG., et al.[2022]
A study involving 100 patients demonstrated that the posterior superior alveolar nerve block (PSANB) alone is effective for pain control during maxillary third molar extractions, reducing the need for additional palatal injections.
The depth of anesthesia achieved with PSANB was sufficient for most cases, with effective coverage extending to the first molar, indicating that this method can simplify the procedure and improve patient comfort.
Posterior superior alveolar nerve block alone in the extraction of upper third molars: a prospective clinical study.Tummalapalli, S., M, RS., Inturi, NMR., et al.[2023]
Continuous mandibular nerve block using a catheter to deliver 0.25% bupivacaine provided excellent pain relief for two patients with mandible fractures, eliminating the need for additional analgesics post-surgery.
This method demonstrated no side effects, suggesting it could be a safe and effective alternative for managing pain in similar surgical procedures or conditions affecting the mandibular region.
Continuous mandibular nerve block for pain relief. A report of two cases.Singh, B., Bhardwaj, V.[2022]

References

The effect of the twin block compared with trigger point injections in patients with masticatory myofascial pain: a pilot study. [2022]
Posterior superior alveolar nerve block alone in the extraction of upper third molars: a prospective clinical study. [2023]
Continuous mandibular nerve block for pain relief. A report of two cases. [2022]
The twin block injection: an adjunctive clinical aid for the management of acute arthrogenous temporomandibular joint dysfunction. [2021]
Post operative pain relief through intermittent mandibular nerve block. [2021]
Efficacy of the twin block, a peripheral nerve block for the management of chronic masticatory myofascial pain: A case series. [2021]
Suprazygomatic Access for Continuous Bilateral Mandibular Nerve Block for Pain and Trismus Relief in the Tetraplegic Patient. [2017]
Ultrasound-guided maxillary nerve block: an anatomical study using the suprazygomatic approach. [2021]
[Percutaneous mandibular nerve block using neuro-stimulation guiding through the sigmoid indentation in facial surgery]. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity